Predictors of Bronchopulmonary Dysplasia in 625 Neonates with Respiratory Distress Syndrome

J Trop Pediatr. 2022 Apr 5;68(3):fmac037. doi: 10.1093/tropej/fmac037.

Abstract

Objective: This study was designed to investigate the predictors of bronchopulmonary dysplasia in neonates with respiratory distress syndrome.

Methods: This was a single-center retrospective cohort study conducted between 1 January 2015 and 31 December 2020. A total of 625 neonates with respiratory distress syndrome (RDS) were enrolled. Demographic data, clinical presentations, complications and related treatment information were collected and analyzed. We used bivariate and multivariate logistic-regression analyses to determine significant predictors of bronchopulmonary dysplasia (BPD) in RDS neonates.

Results: In these 625 neonates, 102 (16.3%) of them developed BPD. Bivariate analysis and multivariate logistic-regression analyses revealed that birthweight, gestational age under 32 weeks, duration of oxygen therapy over 10 days, asphyxia, patent ductus arteriosus, transfusion of red blood cells (packed red blood cells) and surfactant use were significantly associated with the development of BPD.

Conclusion: Birthweight, gestational age <32 weeks, total duration of oxygen therapy >10 days, asphyxia, patent ductus arteriosus, need for red blood cell infusion, and the use of pulmonary surfactant were important predictors of BPD in neonates with RDS.

Keywords: bronchopulmonary dysplasia; neonate; respiratory distress syndrome; risk factors.

MeSH terms

  • Asphyxia
  • Birth Weight
  • Bronchopulmonary Dysplasia* / complications
  • Bronchopulmonary Dysplasia* / epidemiology
  • Ductus Arteriosus, Patent* / complications
  • Gestational Age
  • Humans
  • Infant
  • Infant, Newborn
  • Oxygen
  • Pulmonary Surfactants* / therapeutic use
  • Respiratory Distress Syndrome, Newborn* / epidemiology
  • Respiratory Distress Syndrome, Newborn* / etiology
  • Respiratory Distress Syndrome, Newborn* / therapy
  • Retrospective Studies

Substances

  • Pulmonary Surfactants
  • Oxygen